Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway

Traumatic brain injury (TBI) is a major public health problem and a major cause of mortality and disability that imposes a substantial economic burden worldwide. Dexmedetomidine (DEX), a highly selective α-2-adrenergic receptor agonist that functions as a sedative and analgesic with minimal respirat...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaoyan, Ma, Weiwei, Zhu, Jie, Jiao, Wei, Wang, Yuhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335733/
https://www.ncbi.nlm.nih.gov/pubmed/34278508
http://dx.doi.org/10.3892/mmr.2021.12300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335733/
https://www.ncbi.nlm.nih.gov/pubmed/34278508
http://dx.doi.org/10.3892/mmr.2021.12300

Ejemplares similares